Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.08 B812 M826 M801 M 3.52 B Research & development ———— — Operating income 69 M101 M22 M44 M 236 M Non-Operating Income, Total -34 M-26 M-24 M-23 M -107 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses -65 M-48 M-40 M-53 M -206 M Unusual income/expense 31 M22 M16 M30 M 99 M Pretax income 35 M75 M-2 M21 M 129 M Equity in earnings ———— — Taxes 11 M20 M-1 M-9 M 21 M Non-controlling/minority interest ———— — After tax other income/expense -18 M-3 M-11 M-2 M -34 M Net income before discontinued operations 24 M55 M-1 M30 M 108 M Discontinued operations 000-24 M — Net income 24 M55 M-1 M6 M 84 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 24 M55 M-1 M6 M 84 M Basic earnings per share (Basic EPS) 0.40.91-0.020.1 1.39 Diluted earnings per share (Diluted EPS) 0.390.9-0.020.1 1.37 Average basic shares outstanding 60.1 M60.3 M60 M59.9 M — Diluted shares outstanding 60.9 M61 M60 M60.6 M — EBITDA 139 M154 M78 M-94 M 277 M EBIT 65 M98 M10 M-152 M 21 M Cost of revenue 1.43 B1.08 B1.16 B1.1 B 4.77 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 74 M56 M68 M58 M 256 M